InvestorsHub Logo
Followers 18
Posts 2294
Boards Moderated 0
Alias Born 03/22/2013

Re: None

Monday, 11/11/2019 7:51:40 PM

Monday, November 11, 2019 7:51:40 PM

Post# of 79329
Next comes the patent ..Zimmerman BioPharmaceuticals, Inc, is a biopharmaceutical company that owns a proprietary process that will deliver biosimilar alternatives to biologic medicines at a lower cost to consumers. Its process lowers production costs, improves product cycle time, and delivers greater product stability.
“”””””””Zimmerman's products have been fully validated in pre-clinical trials and testing, and has an FDA recommendation to seek approval through an accelerated process.””””””

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SSOF News